(Q52657489)
Statements
Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. (English)
Ling Ma
Qiao Cheng
10 March 2018
498
4
912-917